EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitNetzwerk-Metaanalyse

Clinical benefits of autologous platelet concentrate in periodontal intrabony defects: A network meta‐analysis of randomized controlled trials

Yue Cui iD, Yuhe Mai iD, Xuewei Liu iD, Hong Mu iD

European Journal of Oral Sciences · 2024-06 · 132 (3)

DOI: 10.1111/eos.12978 ↗

At a glance

Übersichtsarbeit in European Journal of Oral Sciences, published online on 2024-03-08. Written by Yue Cui and 3 co-authors. Institution: Department of Stomatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, P.R. China. Major MEDLINE topics: Randomized Controlled Trials as Topic, Alveolar Bone Loss, Guided Tissue Regeneration, Periodontal. Cited 4 times so far (Crossref); 115 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This study aimed to compare clinical benefits of autologous platelet concentrate with other periodontal regenerative approaches in intrabony defects. An electronic and hand search of studies up to December 2022 was conducted. Randomized controlled trials with at least 6 months of follow‐up were identified to compare autologous platelet concentrates with enamel matrix derivative, bone graft, guided tissue regeneration, and open‐flap debridement. All approaches involved papilla preservation flap surgery. The outcomes included probing depth reduction, clinical attachment level gain, linear bone fill, and safety. A network meta‐analysis and meta‐regression were performed. Fifty‐seven studies were included in five network meta‐analyses. Autologous platelets concentrate and its adjunct treatments achieved significantly greater clinical and radiographic parameters than did open‐flap debridement, and had comparable or better performance than other regenerative treatments. Platelet‐rich fibrin showed superiority over platelet‐rich plasma in probing depth reduction at 6‐month follow‐up. Minimal pain and improved wound healing were observed in the treatments with autologous platelet concentrate. Meta‐regression showed that deeper baseline intrabony defects resulted in larger probing depth reductions, while smoking impaired the effectiveness of regenerative surgeries. Minimal invasive flap designs led to less effect of regenerative materials. Autologous platelet concentrate is a promising biomaterial in periodontal regeneration due to its convenience, safety, and biocompatibility characteristics.

Subjects

MeSH terms (MEDLINE)

Randomized Controlled Trials as TopicAlveolar Bone LossGuided Tissue Regeneration, PeriodontalHumansPlatelet-Rich PlasmaPlatelet-Rich FibrinBlood PlateletsBone TransplantationSurgical FlapsTreatment Outcome

Author keywords

papilla preservation flapperiodontal regenerationplatelet‐rich fibrinprognostic factor

Authors and institutions

  • Department of Stomatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, P.R. China.

ORCID profiles: Yue Cui, Yuhe Mai, Xuewei Liu, Hong Mu

Cite

APA

Cui, Y., Mai, Y., Liu, X., & Mu, H. (2024). Clinical benefits of autologous platelet concentrate in periodontal intrabony defects: A network meta‐analysis of randomized controlled trials. European Journal of Oral Sciences, 132(3). https://doi.org/10.1111/eos.12978

Vancouver

Cui Y, Mai Y, Liu X, Mu H. Clinical benefits of autologous platelet concentrate in periodontal intrabony defects: A network meta‐analysis of randomized controlled trials. European Journal of Oral Sciences. 2024;132(3). doi:10.1111/eos.12978

BibTeX
@article{Cui2024,
  author = {Cui, Yue and Mai, Yuhe and Liu, Xuewei and Mu, Hong},
  title = {Clinical benefits of autologous platelet concentrate in periodontal intrabony defects: A network meta‐analysis of randomized controlled trials},
  journal = {European Journal of Oral Sciences},
  year = {2024},
  volume = {132},
  number = {3},
  doi = {10.1111/eos.12978}
}
Start for free →